Baird Mocks Einhorn Over AthenaHealth PresentationVW Staff
Analysts with bull ratings on athenahealth, Inc (NASDAQ:ATHN) are rushing to the company's defense after David Einhorn's very public short attack. Baird's latest report defends athenahealth's growth targets vehemently while reducing their price target to $175. The report explains that the change in PT has nothing to do with the short seller's comments and is only based on industry multiples, which have compressed dramatically in the past months. Baird is bullish on athena and believes that it will go on to . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.